p53 codon 72 polymorphism interactions with dietary and tobacco related habits and risk of stomach cancer in Mizoram, India

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 2, 2014, Pages 717-723

  Malakar, Mridul ^a,c   Devi, K Rekha ^a   Phukan, Rup Kumar ^a   Kaur, Tanvir ^b   Deka, Manab ^c   Puia, Lalhriat ^d   Sailo, Lalrinliana ^d   Lalhmangaihi, T ^d   Barua, Debajit ^e   Rajguru, Sanjib Kumar ^a   Mahanta, Jagadish ^a   Narain, Kanwar ^a  

^a REGIONAL MEDICAL RESEARCH CENTRE   (India)

^b INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^c GAUHATI UNIVERSITY   (India)

^d Directorate of Hospital and Medical Education   (India)

^e Aizawl Endoscopy Centre   (India)

Author keywords

Gene environment interactions; Mizoram, India; p53 codon 72 polymorphism; Risk habits; Stomach cancer

Indexed keywords

PROTEIN P53; TP53 PROTEIN, HUMAN;

ARTICLE; CANCER STAGING; CASE CONTROL STUDY; CODON; COMPARATIVE STUDY; DRINKING BEHAVIOR; FEEDING BEHAVIOR; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INDIA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SMOKING; STOMACH TUMOR;

ALCOHOL DRINKING; CASE-CONTROL STUDIES; CODON; FEMALE; FOLLOW-UP STUDIES; FOOD HABITS; GENE-ENVIRONMENT INTERACTION; GENOTYPE; HUMANS; INDIA; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS; RISK FACTORS; SMOKING; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84894653505     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.2.717     Document Type: Article

References (52)

1. Ara S, Lee PS, Hansen MF, et al (1990). Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res, 18, 4961.
2. Beckman G, Birgander R, Sjalander A, et al (1994). Is p53 polymorphism maintained by natural selection?, Human heredity, 44, 266-70.
3. Birgander R, Sjalander A, Zhou Z, et al (1996). p53 polymorphisms and haplotypes in nasopharyngeal cancer. Hum Hered, 46, 49-54.
4. Breslow NE, Day NE (1980). Statistical methods in cancer research. In Volume I-The analysis of case-control studies, IARC Sci Publ, 5, 338.
5. Cai L, Mu LN, Lu H, et al (2006). Dietary selenium intake and genetic polymorphisms of the GSTP1 and p53 genes on the risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev, 15, 294-300.
6. Correa P (1992). Human gastric carcinogenesis: a multistep and multifactorial process. In first American cancer society award lecture on cancer epidemiology and prevention, Cancer Res, 52, 6735-40.
7. De Feo E, Persiani R, La Greca A, et al (2009). A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression. Mutat Res, 675, 60-5.
8. Dhingra K, Hortobagyi GN (1996). Critical evaluation of prognostic factors. Semin Oncol, 23, 436-45.
9. Finlay CA, Hinds PW, Levine AJ (1989). The p53 proto-oncogene can act as a suppressor of transformation. Cell, 57, 1083-93.
10. Francisco G, Menezes PR, Eluf-Neto J, et al (2011). Arg72Pro TP53 polymorphism and cancer susceptibility: a comprehensive meta-analysis of 302 case-control studies. Int J Cancer, 129, 920-30.
11. Gao L, Nieters A, Brenner H (2009). Cell proliferation-related genetic polymorphisms and gastric cancer risk: systematic review and meta-analysis. Eur J Hum Genet, 17, 1658-67.
12. Garcia-Gonzalez MA, Quintero E, Bujanda L, et al (2012). Relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotype. Mutagenesis, 27, 771-7.
13. Hansson LE, Baron J, Nyren O, et al (1994). Tobacco, alcohol and the risk of gastric cancer. A population-based case-control study in Sweden. Int J Cancer, 57, 26-31.
14. He XF, Su J, Zhang Y, et al (2011). Association between the p53 polymorphisms and breast cancer risk: meta-analysis based on case-control study. Breast Cancer Res Treat, 130, 517-29.
15. Hiyama T, Tanaka S, Kitadai Y, et al (2002). p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis. Int J Cancer, 100, 304-8.
16. Ihsan R, Devi TR, Yadav DS, et al (2011). Investigation on the role of p53 codon 72 polymorphism and interactions with tobacco, betel quid, and alcohol in susceptibility to cancers in a high-risk population from North East India. DNA Cell Biol, 30, 163-71.
17. Karim S, Ali A (2009). Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India. World J Gastroenterol, 15, 1381-7.
18. Katkoori VR, Jia X, Shanmugam C, et al (2009). Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma. Clin Cancer Res, 15, 2406-16.
19. Ke-Xiang Z, Yu-Min L, Xun L, et al (2012). Study on the association of p53 codon 72 polymorphisms with risk of gastric cancer in high incidence Hexi area of Gansu Province in China. Mol Biol Rep, 39, 723-8.
20. Matlashewski GJ, Tuck S, Pim D, et al (1987). Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol, 7, 961-3.
21. Mojtahedi Z, Haghshenas MR, Hosseini SV, et al (2010). p53 codon 72 polymorphism in stomach and colorectal adenocarcinomas in Iranian patients. Indian J Cancer, 47, 31-4.
22. Mu LN, Lu QY, Yu SZ, et al (2005). Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population. Int J Cancer, 116, 972-83.
23. NCRP (National Cancer Registry Programme) (2010). Three year report of the population based cancer registries 2006-2008. (First report of 20 PBCRs in India), Bangalore. Indian Council Med Res Publ, 11, 71-8.
24. Pandith AA, Shah ZA, Khan NP, et al (2010). Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population. Cancer Genet Cytogenet, 203, 263-8.
25. Papadakis EN, Dokianakis DN, Spandidos DA (2000). p53 codon 72 polymorphism as a risk factor in the development of breast cancer. Mol Cell Biol Res Commun, 3, 389-92.
26. Phukan RK, Hazarika NC, Baruah D, et al (2004). High prevalence of stomach cancer among the people of Mizoram, India. Curr Sci, 87, 285-6.
27. Phukan RK, Zomawia E, Narain K, et al (2005). Tobacco use and stomach cancer in Mizoram, India. Cancer Epidemiol Biomarkers Prev, 14, 1892-96.
28. Phukan RK, Narain K, Zomawia E, et al (2006). Dietary habits and stomach cancer in Mizoram, India. J Gastroenterol, 41, 418-24.
29. Rao DN, Ganesh B (1998). Estimate of cancer incidence in India in 1991. Indian J Cancer, 35, 10-18.
30. Rao DN, Ganesh B, Dinshaw KA, et al (2002). A case-control study of stomach cancer in Mumbai, India. Int J Cancer, 99, 727-31.
31. Renault B, van den Broek M, Fodde R, et al (1993). Base transitions are the most frequent genetic changes at p53 in gastric cancer. Cancer Res, 53, 2614-7.
32. Russo A, Maconi G, Spinelli P, et al (2001). Effect of lifestyle, smoking and diet on development of intestinal metaplasia in H pylori-positive subjects. Am J Gastroenterol, 96, 1402-8.
33. Sameer AS, Shah ZA, Syeed N, et al (2010). TP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population. Genet Mol Res, 9, 651-60.
34. Shao Y, Tan W, Zhang S (2008). P53 gene codon 72 polymorphism and risk of esophageal squamous cell carcinoma: a case/control study in a Chinese population. Dis Esophagus, 21, 139-43.
35. Shepherd T, Tolbert D, Benedetti J, et al (2000). Alterations in exon 4 of the p53 gene in gastric carcinoma. Gastroenterology, 118, 1039-44.
36. Siddiqi M, Kumar R, Fazili Z, et al (1992). Increased exposure to dietary amines and nitrate in a population at high risk of oesophageal and gastric cancer in Kashmir (India). Carcinogenesis, 13, 1331-5.
37. Sjalander A, Birgander R, Hallmans G, et al (1996). p53 polymorphisms and haplotypes in breast cancer. Carcinogenesis, 17, 1313-16.
38. Sul J, Yu GP, Lu QY, et al (2006). P53 Codon 72 polymorphisms: a case-control study of gastric cancer and potential interactions. Cancer Lett, 238, 210-23.
39. Sumathi B, Ramalingam S, Navaneethan U, et al (2009). Risk factors for gastric cancer in South India. Singapore Med J, 50, 147-51.
40. Tamura G, Kihana T, Nomura K, et al (1999). Detection of Frequent p53 Gene Mutations in Primary Gastric Cancer by Cell Sorting and Polymerase Chain Reaction Single-Strand Conformation Polymorphism Analysis. Cancer Res, 51, 3056-8.
41. Thomas M, Kalita A, Labrecque S, et al (1999). Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol, 19, 1092-100.
42. Tredaniel J, Boffetta P, Buiatti E, et al (1997). Tobacco smoking and gastric cancer: review and meta-analysis. Int J Cancer, 72, 565-73.
43. Walker KK, Levine AJ (1996). Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci, 93, 15335-40.
44. Wang YC, Lee HS, Chen SK, et al (1999). Prognostic significance of p53 codon 72 polymorphism in lung carcinomas. Eur J Cancer, 35, 226-30.
45. Ward MH, Lopez-Carrillo L (1999). Dietary factors and the risk of gastric cancer in Mexico City. Am J Epidemiol, 149, 925-32.
46. Weng Y, Lu L, Yuan G, et al (2012). p53 codon 72 polymorphism and hematological cancer risk: an update meta-analysis. PloS one, 7, 45820.
47. Wu MT, Chen MC, Wu DC (2004). Influences of lifestyle habits and p53 codon 72 and p21 codon 31 polymorphisms on gastric cancer risk in Taiwan. Cancer Lett, 205, 61-8.
48. Xiang B, Mi YY, Li TF (2012). Updated meta-analysis of the TP53 Arg72Pro polymorphism and gastric cancer risk. Asian Pac J Cancer Prev, 13, 1787-91.
49. Yang M, Guo Y, Zhang X, et al (2007). Interaction of P53 Arg72Pro and MDM2 T309G polymorphisms and their associations with risk of gastric cardia cancer. Carcinogenesis, 28, 1996-2001.
50. Zhang ZW, Newcomb P, Hollowood A, et al (2003). Age-associated increase of codon 72 Arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma. Clin Cancer Res, 9, 2151-6.
51. Zhang Z, Wang M, Wu D, et al (2010). P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case-control studies. Breast Cancer Res Treat, 120, 509-17.
52. Zhou Y, Li N, Zhuang W, et al (2007). P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature. Int J Cancer, 121, 1481-86.